Millipore Sigma Vibrant Logo

410957 3-Isobutyl-1-methylxanthine - CAS 28822-58-4 - Calbiochem

View This Product on Sigma-Aldrich
410957
価格&在庫状況を照会

概要

Replacement Information

主要スペック表

CAS #Empirical Formula
28822-58-4C₁₀H₁₄N₄O₂

価格&在庫状況

カタログ番号 在庫状況包装 Qty/Pk 価格 数量
410957-1GMCN
在庫状況検索中…
現在国内在庫なし
現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      Contact Customer Service

      樹脂アンプル 1 gm
      価格を検索中…
      価格が見つかりません
      Minimum Quantity needs to be mulitiple of
      Maximum Quantity is
      弊社照会 詳細を表示 
      値引
      ()
       
      弊社照会
      410957-250MGCN
      在庫状況検索中…
      現在国内在庫なし
現在国内在庫なし
      現在国内在庫有り 
      販売中止
      在庫僅少
      現在国内在庫あり
        Remaining : Will advise
          Remaining : Will advise
          注文対象外
          お問合せください
          Contact Customer Service

          樹脂アンプル 250 mg
          価格を検索中…
          価格が見つかりません
          Minimum Quantity needs to be mulitiple of
          Maximum Quantity is
          弊社照会 詳細を表示 
          値引
          ()
           
          弊社照会
          Description
          OverviewA cell-permeable, non-specific inhibitor of cAMP and cGMP phosphodiesterases (IC50 = 2-50 µM). Also acts as an adenosine receptor antagonist. Reported to inhibit TNF-α expression in adipocyte precursor cells.
          Catalogue Number410957
          Brand Family Calbiochem®
          SynonymsIBMX
          References
          ReferencesHube, F., et al. 1999. Horm. Metab. Res. 31, 359.
          Morgan, A.J., et al. 1993. Biochem. Pharmacol. 45, 2373.
          Scamps, F., et al. 1993. Eur. J. Pharmacol. 244, 119.
          Turner, N.C., et al. 1993. Br. J. Pharmacol. 108, 876.
          Tamura, T., et al. 1991. J. Gen. Physiol. 98, 95.
          Beavo, J.A., and Reifsnyder, D.H. 1990. Trends Pharmacol. Sci. 11, 150.
          Russell, T.R. 1979. Proc. Natl. Acad. Sci. USA 76, 4451.
          Product Information
          CAS number28822-58-4
          ATP CompetitiveN
          FormWhite solid
          Hill FormulaC₁₀H₁₄N₄O₂
          Chemical formulaC₁₀H₁₄N₄O₂
          ReversibleN
          Structure formula ImageStructure formula Image
          Quality LevelMQ100
          Applications
          Application3-Isobutyl-1-methylxanthine, CAS 28822-58-4, is a cell-permeable, non-specific inhibitor of cAMP and cGMP phosphodiesterases (IC50 = 2-50 µM).
          Biological Information
          Primary TargetcAMP and cGMP phosphodiesterases
          Primary Target IC<sub>50</sub>2-50 µM against cAMP and cGMP phosphodiesterases
          Purity≥98% by HPLC
          Physicochemical Information
          Cell permeableY
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          RTECSZD8500000
          Safety Information
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Ambient Temperature Only
          Toxicity Standard Handling
          Storage -20°C
          Do not freeze Ok to freeze
          Special InstructionsFollowing reconstitution in ethanol or methanol, refrigerate (4°C). Following reconstitution in DMSO, aliquot and freeze (-20°C). Ethanol/methanol and DMSO stock solutions are stable for up to 6 months at 4°C or -20°C, respectively.
          Packaging Information
          Transport Information
          Supplemental Information
          Specifications
          Global Trade Item Number
          カタログ番号 GTIN
          410957-1GMCN 04055977211139
          410957-250MGCN 04055977211146

          Documentation

          3-Isobutyl-1-methylxanthine - CAS 28822-58-4 - Calbiochem (M)SDS

          タイトル

          英語版製品安全データシート((M)SDS) 

          3-Isobutyl-1-methylxanthine - CAS 28822-58-4 - Calbiochem 試験成績書(CoA)

          タイトルロット番号
          410957

          参考資料

          参考資料の概要
          Hube, F., et al. 1999. Horm. Metab. Res. 31, 359.
          Morgan, A.J., et al. 1993. Biochem. Pharmacol. 45, 2373.
          Scamps, F., et al. 1993. Eur. J. Pharmacol. 244, 119.
          Turner, N.C., et al. 1993. Br. J. Pharmacol. 108, 876.
          Tamura, T., et al. 1991. J. Gen. Physiol. 98, 95.
          Beavo, J.A., and Reifsnyder, D.H. 1990. Trends Pharmacol. Sci. 11, 150.
          Russell, T.R. 1979. Proc. Natl. Acad. Sci. USA 76, 4451.

          カタログ

          タイトル
          Activators and Inhibitors of Adenylate Cyclase Technical Bulletin
          データシート

          Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

          Revision12-July-2013 JSW
          SynonymsIBMX
          DescriptionA non-specific, cell-permeable inhibitor of cAMP and cGMP phosphodiesterases (IC50 = 2-50 µM). Also acts as an adenosine receptor antagonist. Reported to inhibit TNFα expression in adipocyte precursor cells.
          FormWhite solid
          CAS number28822-58-4
          RTECSZD8500000
          Chemical formulaC₁₀H₁₄N₄O₂
          Structure formulaStructure formula
          Purity≥98% by HPLC
          SolubilityDMSO (100 mM), Ethanol (10 mg/ml), or Methanol (50 mg/ml). Heating may be required to achieve complete solubilization.
          Storage -20°C
          Do Not Freeze Ok to freeze
          Special InstructionsFollowing reconstitution in ethanol or methanol, refrigerate (4°C). Following reconstitution in DMSO, aliquot and freeze (-20°C). Ethanol/methanol and DMSO stock solutions are stable for up to 6 months at 4°C or -20°C, respectively.
          Toxicity Standard Handling
          ReferencesHube, F., et al. 1999. Horm. Metab. Res. 31, 359.
          Morgan, A.J., et al. 1993. Biochem. Pharmacol. 45, 2373.
          Scamps, F., et al. 1993. Eur. J. Pharmacol. 244, 119.
          Turner, N.C., et al. 1993. Br. J. Pharmacol. 108, 876.
          Tamura, T., et al. 1991. J. Gen. Physiol. 98, 95.
          Beavo, J.A., and Reifsnyder, D.H. 1990. Trends Pharmacol. Sci. 11, 150.
          Russell, T.R. 1979. Proc. Natl. Acad. Sci. USA 76, 4451.